We are live on ! Find out more
DG

David Goel Matrix Capital Management Company

AUM $46.3M
1-Year Est. Return 114.38%
 

David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.

This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$2.15B
AUM Growth
+$56.7M
Cap. Flow
-$136M
Cap. Flow %
-6.31%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GFS icon
GlobalFoundries
GFS
+$94.3M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$35.8M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$3.33M
4
PRM icon
Perimeter Solutions
PRM
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 91.5%
2 Healthcare 4.61%
3 Materials 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTR
1
DELISTED
Altair Engineering Inc
ALTR
$1.36B 63.04%
12,430,000
– –
GFS icon
2
GlobalFoundries
GFS
$26.4B
$612M 28.45%
14,264,952
-2,250,000
-14% -$94.3M
PRM icon
3
Perimeter Solutions
PRM
$5.15B
$83.8M 3.89%
6,554,000
-171,000
-3% -$2.23M
AURA icon
4
Aura Biosciences
AURA
$809M
$56.9M 2.65%
6,922,870
– –
ZNTL icon
5
Zentalis Pharmaceuticals
ZNTL
$363M
$42.3M 1.97%
13,959,973
– –
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-37,681,515
Closed -$35.8M
ADPT icon
7
Adaptive Biotechnologies
ADPT
$4.15B
– –
-650,000
Closed -$3.33M

Similar funds

RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
IPHI
Inflection Point Holdings II New York $47.3M AUM
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
BAM
BLKBRD Asset Management Old Greenwich, Connecticut $38.3M AUM 34.49% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CM
CoinFund Management New York $35.4M AUM

David Goel's Q4 2024 Portfolio in Review

As of Q4 2024, David Goel held 7 positions worth $2.15B, up 2.7% from $2.09B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

David Goel withdrew a net $136M in Q4 2024, closing 2 positions and reducing 2 holdings. Its most notable exit was Adaptimmune Therapeutics, an estimated $35.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 91% of assets, up from 88% a quarter earlier, followed by Healthcare and Materials.

  • David Goel's biggest Q4 2024 reduction was GlobalFoundries, cutting an estimated $94.3M.
  • David Goel fully exited Adaptimmune Therapeutics in Q4 2024, selling an estimated $35.8M.
  • David Goel's ten largest holdings make up 100% of its $2.15B portfolio in Q4 2024.
  • David Goel opened 0 new positions and closed 2 in Q4 2024.
  • David Goel's portfolio value rose 2.7% quarter-over-quarter to $2.15B.

Based on Matrix Capital Management Company's 13F filing for Q4 2024, filed 13 Feb 2025.